Peptide Fox
FoxAINew
Download on the App StorePeptideFox for iPhoneFree on the App Store
AboutiOS AppArticlesPeptide LibraryCalculatorSupportPrivacy

© 2026 PeptideFox. For research and educational purposes only.

    GLP-1s

    Semaglutide, tirzepatide, and retatrutide are three different receptor strategies — not three doses of the same drug. Each one answers the same question about hunger, fat, and lean mass in a different way.

    Ask FoxAIPeptide research chat backed by the PeptideFox knowledge graph and peer-reviewed papers.

    Three compounds, three receptor strategies. Semaglutide activates GLP-1 alone — SELECT showed a 20% cardiovascular event reduction in obesity with established heart disease. Tirzepatide adds GIP and delivered 47% more weight loss than semaglutide in the head-to-head SURMOUNT-5 trial. Retatrutide adds glucagon on top, pushing the weight-loss ceiling higher and mobilizing liver fat directly, though it remains investigational. Pick by the outcome you need, not the headline number.

    Compare GLP-1 Compounds

    The receptor pharmacology dictates the fat-vs-lean outcome, the side-effect pattern, and what happens when you stop — compare the three before picking.

    Open tool

    Browse other categories:PeptidesProtocolsGuides

    Compound Guides

    SemaglutideOzempic•Wegovy

    Semaglutide dosing ranges from 0.25mg to 2.4mg a week. How much weight loss to expect by dose, side effects during titration, and if Ozempic or Wegovy is right for you.

    Read guide→

    TirzepatideMounjaro•Zepbound

    Tirzepatide dosing ranges from 2.5mg to 15mg. Explore trial data for weight loss, side effects vs. semaglutide, and if Mounjaro or Zepbound makes sense for you.

    Read guide→

    RetatrutideTriple-Agonist GLP-1

    Retatrutide is the next evolution of Ozempic and Mounjaro — hitting GLP-1, GIP, and glucagon receptors simultaneously — fundamentally altering metabolic health.

    Read guide→

    Deep Dives

    GLP-1 FatigueWhy It Happens and What Helps

    GLP-1 fatigue explained: why semaglutide, tirzepatide, and retatrutide cause tiredness, which compound causes more, and evidence-based fixes from protein to mitochondrial support.

    Read guide→

    GLP-1s and Cholesterol

    GLP-1 drugs also improve lipid panels—lowering triglycerides, shifting LDL, and reducing liver fat. Trial data for semaglutide, tirzepatide, and retatrutide.

    Read guide→

    Oral GLP-1 OptionsWegovy Pill•Orforglipron

    There's now a pill version of semaglutide, and orforglipron is coming. How they compare on weight loss, side effects, and cost — and if its right for you.

    Read guide→

    Support Stacks for GLP-1sPreserving Lean Mass

    Semaglutide and Tirzepatide can cause up to 40% muscle loss. Learn why, what 'Ozempic face' actually is, and the evidence-based protocol to prevent it.

    Read guide→

    Protocols

    NAD+ for RetatrutideCritical Support Layer for GLP-1s

    Retatrutide creates a powerful caloric deficit, but needs NAD+ to oxidize fat and prevent energy crashes. Full protocol — dosing, timing, and what to expect.

    Read guide→

    NAD+ and MOTS-c for EnergyThe Two-Compound Mito Stack

    The NAD+ and MOTS-c stack restores the cellular adaptation loop that metabolic stress and age erodes, increasing energy by burning fat for fuel. Full protocol with dosing breakdowns and a 12-week timeline.

    Read guide→

    Retatrutide: Advanced StackDual-Axis Protocol to Protect Lean Mass

    A novel protocol for Retatrutide to preserve lean mass and shift your metabolism to prefer fat for energy using MOTS-c, Tesamorelin, L-Carnitine, and NAD+.

    Read guide→